ESTRO 2025 - Abstract Book

S1269

Clinical – Lower GI

ESTRO 2025

Conclusion: This analysis shows that the ERI is able to identify patients who may benefit from dose escalation, with increased CR in non-responder patients.

Keywords: Rectal cancer, MRIgRT, Early regression index